MAPT and myotonic dystrophy type 1: Considering the available evidence, we postulate that tyrosine 18 is abnormally phosphorylated in DM1, in which case our assay would be expected to have the lowest sensitivity in patients with the highest levels of tau pathology by way of increased phosphorylation.